Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.20.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XVNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.38.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.80NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.134NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BY.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.42NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAY.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20469.9US
XBB.1.46NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.17.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.562NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.219NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
N.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XANSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AZ.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.114NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.199NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BY.1.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.11.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.63NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FM.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.10.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-19772US
EG.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.13.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.424NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.64NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.1.327NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.396NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.129NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AK.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.221.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.224NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.618NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used